antifungal skin reactions david w. denning university hospital of south manchester the university of...
TRANSCRIPT
![Page 1: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/1.jpg)
Antifungal skin reactions
David W. DenningUniversity Hospital of South
ManchesterThe University of Manchester
![Page 2: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/2.jpg)
Itraconazole and exanthematous pustulosis
Heymann J Am Acad Dermatol 1995;33:130; Min Park, JAAD 1997;36:754
Bx showed neutrophils in epidermis and neutrophils and eosinophils in the dermis
![Page 3: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/3.jpg)
Itraconazole erythematous eruption (AIDS)
www.aspergillus.org.uk
![Page 4: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/4.jpg)
Itraconazole and reported cutaneous reactions in the literature
Unpublished
Adverse events Number of patients
Total number patients 9065
Cutaneous side effects
Rash/pruritus 250
Alopecia 19
Site reaction / vasculitis 4
Steven-Johnson syndrome 2
Hirsuitism 1
Photosensitivity 1
Diaphoresis 1
![Page 5: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/5.jpg)
Patient 1
Unpublished
•AW (♂, age 56) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and voriconazole
CPA had developed on a background of sarcoidosis. The only concurrent treatment was prednisolone 5mg.
![Page 6: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/6.jpg)
Patient 1
Unpublished
July 2010
Aug 2009
![Page 7: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/7.jpg)
Patient 1
Unpublished
•AW (♂, age 56) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and voriconazole
CPA had developed on a background of sarcoidosis. The only concurrent treatment was prednisolone 5mg.
Random therapeutic drug monitoring (TDM) revealed levels of 2.3mg/l (normal range > 0.5 mg/l).
Within one month of commencing posaconazole he developed a sparse papular rash on his face and forearms.
The rash did not progress and the patient continues on posaconazole.
![Page 8: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/8.jpg)
Patient 2
Unpublished
• DC (♂, age 73) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and voriconazole.
CPA had developed on a background of asthma and ABPA. He also had severe aortic stenosis. Treatments included inhaled salmeterol/fluticasone 50/500mcg twice daily and prednisolone 5mg.
![Page 9: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/9.jpg)
Patient 2
Unpublished
Jan 2010
Oct 2008
![Page 10: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/10.jpg)
Patient 2
Unpublished
• DC (♂, age 73) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and voriconazole.
CPA had developed on a background of asthma and ABPA. He also had severe aortic stenosis. Treatments included inhaled salmeterol/fluticasone 50/500mcg twice daily and prednisolone 5mg.
Random TDM revealed levels of 2.8mg/l.
Within forty-eight hours of commencing posaconazole he developed a severe acneifrom rash, typical of folliculitis, across his face.
![Page 11: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/11.jpg)
Patient 2
Unpublished
![Page 12: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/12.jpg)
Patient 2
Unpublished
• Within one week the rash had progressed to cover his neck, ears, scalp and upper chest wall.
Posaconazole was discontinued due to the severe nature of the eruption.
![Page 13: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/13.jpg)
Patient 3
Unpublished
• JB (♂, age 61) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity.
He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250mcg 2 puffs twice daily and tiotropium 18mcg daily.
Random TDM revealed levels of 2.6, mg/l.
Within two weeks of commencing posaconazole he developed a sparse acneifrom rash on his face. A similar eruption had occurred on itraconazole.
The rash did not progress and the patient continues on posaconazole.
![Page 14: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/14.jpg)
Patient 3
Unpublished
• JB (♂, age 61) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity.
He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250mcg 2 puffs twice daily and tiotropium 18mcg daily.
![Page 15: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/15.jpg)
Patient 3
Unpublished
Nov 2008
Sept 2008
![Page 16: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/16.jpg)
Patient 3
Unpublished
![Page 17: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/17.jpg)
Patient 3
Unpublished
• JB (♂, age 61) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole and intolerance of voriconazole due to photosensitivity.
He had developed CPA following resection of lung cancer. Treatment included salmeterol/fluticasone 25/250mcg 2 puffs twice daily and tiotropium 18mcg daily.
Random TDM revealed levels of 2.6, mg/l.
Within two weeks of commencing posaconazole he developed a sparse acneifrom rash on his face. A similar eruption had occurred on itraconazole.
The rash did not progress and the patient continues on posaconazole.
![Page 18: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/18.jpg)
Patient 4
Unpublished
• NC (♂, age 73) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole.
He had developed CPA following resection of lung cancer. He had had psoriasis for years, with little trouble and almost no treatment. Treatment included salmeterol/fluticasone 25/250mcg 2 puffs twice daily and tiotropium 18mcg daily.
![Page 19: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/19.jpg)
Patient 4
Unpublished
Jan 2010
![Page 20: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/20.jpg)
Patient 4
Unpublished
• NC (♂, age 73) was commenced on posaconazole 400mg twice daily following progression of CPA despite itraconazole.
He had developed CPA following resection of lung cancer. He had had psoriasis for years, with little trouble and almost no treatment. Treatment included salmeterol/fluticasone 25/250mcg 2 puffs twice daily and tiotropium 18mcg daily.
Random TDM revealed levels of 2.6, mg/l.
After 3 weeks of posaconazole he had a remarkable exacerbation of psoriasis. He developed psoriatic plaques on his hands for the first time ever. The plaques on his lower legs became confluent. This occurred in association with worsening chest symptoms, notably increased coughing, more breathlessness and increasing oxygen requirement.
![Page 21: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/21.jpg)
Patient 4
Unpublished
![Page 22: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/22.jpg)
Patient 4
Unpublished
![Page 23: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/23.jpg)
Patient 4
Unpublished
• Posaconazole was stopped after 3 weeks, and 2 weeks later he was still very symptomatic with his chest. This responded to a 2 week course of corticosteroids, and his psoriasis also improved.
![Page 24: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/24.jpg)
Posaconazole and rash
Unpublished
• A search of Medline and Embase databases revealed no previous reports of adverse cutaneous reactions due to posaconazole.
The UK and US data sheets describe ‘rash’ (unspecified) as common, mouth ulceration and alopecia as uncommon and Stevens Johnson Syndrome and ‘vesicular rash’ as rare.
![Page 25: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/25.jpg)
Voriconazole
![Page 26: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/26.jpg)
Cheilitis, conjunctivitis and facial erythema with voriconazole
![Page 27: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/27.jpg)
Voriconazole and photosensitivity (phototoxic
reaction)
Denning & Griffiths J Exp Dermatol 2001;26:648
52
![Page 28: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/28.jpg)
Voriconazole, photosensitivity and sunshine
Denning & Griffiths J Exp Dermatol 2001;26:648
![Page 29: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/29.jpg)
Photosensitivity and cutaneous blistering with voriconazole
WWW.aspergillus.org.uk
Voriconazole has ‘uncovered’ pophyria cutanea tarda, and may be mistaken for it (pseudoporphyria)
![Page 30: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/30.jpg)
Voriconazole and pseudoporphyria
Medscape
![Page 31: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/31.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
• AB (♀, age 40) treated with voriconazole (Study 003) having failed itraconazole. She was the first patient in the world with aspergillosis to be treated with voriconazole.
Chronic invasive Aspergillus sinusitis and osteomyelitis of the base of the skull, with cranial neuropathies.
![Page 32: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/32.jpg)
Patient 5
Swift & Denning J Otol Laryngol 1998;112:92
![Page 33: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/33.jpg)
Patient 5
Swift & Denning J Otol Laryngol 1998;112:92
Right hypglossal nerve palsy
Right lateral rectus palsy
![Page 34: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/34.jpg)
Patient 5
Swift & Denning J Otol Laryngol 1998;112:92
![Page 35: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/35.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
•AB (♀, age 40) treated with voriconazole having failed itraconazole
Chronic invasive Aspergillus sinusitis and osteomyelitis of the base of the skull.
Past history of acne rosacea (5 years of antibiotics), not present on starting voriconazole. She received voriconazole for 411 days, 200mg twice daily, starting on 12 July, 1993. After 4 weeks of therapy she developed cheilitis.
![Page 36: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/36.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
She then went on holiday in the UK (Lincolnshire) for 2 weeks.
At 8 weeks of therapy she reported erythema of her face, upper-chest and ears. Her legs and arms tanned normally.
Facial erythema and cheilitis apparent at each outpatient visit although less marked in February 1994.
Summer of 1994, the facial erythema was worse following a holiday at the Mediterranean during which she had used SPF-15 sunscreen.
![Page 37: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/37.jpg)
Patient AB.First patient (in the world) with aspergillosis treated with voriconazole. Enrolled 2 July 1993
Patient 5
Swift J Otol Laryngol 1998;112:92. Denning & Griffiths J Exp Dermatol 2001;26:648
![Page 38: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/38.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
July 1994 she developed slightly pruritic, non-tender, 1-2cm diameter red plaques on both sides of her neck.
![Page 39: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/39.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
![Page 40: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/40.jpg)
Patient 5
Denning & Griffiths J Exp Dermatol 2001;26:648
July 1994 she developed slightly pruritic, non-tender, 1-2cm diameter red plaques on both sides of her neck.
These plaques were clinically and histologically consistent with a diagnosis of discoid lupus erythematosus.
Sunscreen of SPF-30 was recommended and some improvement was noted a month later. Her neck lesions and general erythema improved further over the following six weeks. Treatment with voriconazole was then stopped (completion of therapy).
All her cutaneous abnormalities resolved over the following four months and she is free of aspergillosis three years later.
![Page 41: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/41.jpg)
Pustular phototoxic reaction with voriconazole
![Page 42: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/42.jpg)
Voriconazole adverse events in asthmatics
Chisimba, J Asthma In press
![Page 43: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/43.jpg)
Voriconazole photosensitivity – cause?
Inhibition of all-trans retinol (vitamin A)?
5/6 CF children developed photosensitivity, all on vitamin A supplementation
The imidazole liarazole blocks retinoic acid 4-hydroxylase, raising all-trans retinoic acid
![Page 44: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/44.jpg)
Patient 6
www.aspergillus.org.uk
LT (♀, age 49) lifelong asthma and atopy, with ABPA diagnosed in 1993. Recognised to have CPA complicating ABPA in 2001, but the CPA diagnosis was apparent but made in 1993.
Recurrent infective exacerbations and colonisation by Aspergillus fumigatus and Pseudomonas aeruginosa. Treated with oral itraconazole.
![Page 45: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/45.jpg)
Patient 6
www.aspergillus.org.uk
![Page 46: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/46.jpg)
Patient 6
Better pulmonary status on voriconazole initially, but then slow deterioration,
On 4l/min oxygen dependent 24 hours a day.
Mild photosensitivity on voriconazole, even with little sun exposure. As wheelchair bound very little outside time, so mostly indoor light.
She developed rough scaly patches over her face, neck and lower arms. Dermatological review indicated “multiple solar keratoses”.
www.aspergillus.org.uk
![Page 47: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/47.jpg)
Patient 6
Skin biopsy from the right forearm confirmed this clinical diagnosis – “skin showing hyperkeratosis with a little parakeratosis and acanthosis. The keratinocytes have a glassy appearance but show nuclear atypia with dyskeratotic cells, and occasional suprabasal mitoses. The intraepidermal sweat ducts are spared. Appearances suggest an actinic keratosis with moderate to severe dysplasia.” These features are characteristic of a low grade premalignant change.
She was treated with local 5-fluorouracil cream (Efudix) (3 cycles) to the affected lesions.
www.aspergillus.org.uk
![Page 48: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/48.jpg)
Patient 6
www.aspergillus.org.uk
![Page 49: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/49.jpg)
Patient 6
www.aspergillus.org.uk
![Page 50: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/50.jpg)
Patient 6
These photos were taken at the apogee of inflammation. The inflammation resolved after discontinuing the cream. This reaction is expected with application of this mild chemotherapy agent.
Following treatment her skin was much softer and considerably improved. Voriconazole has been stopped, and posaconazole substituted.
![Page 51: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/51.jpg)
Patient 6
18 months later, new lesion on her forearm.
![Page 52: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/52.jpg)
Patient 6
Biopsy showed squamous cell carcinoma in situ
![Page 53: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/53.jpg)
Voriconazole and skin cancer
![Page 54: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/54.jpg)
McCarthy Clin Infect Dis 2007;44:e55
CGD and hyper IgE syndrome, aggressive multifocal SCCs, voriconazole for 4.5 yrs
![Page 55: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/55.jpg)
Miller Arch Dermatol 2010;146:300
Multiple melanomas in situ, voriconazole for 3 yrs
CGD, multiple melanomas in situ, voriconazole for 4.5 yrs
![Page 56: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/56.jpg)
Cowen, J Am Acad Dermatol 2010;62:31
ALL, multiple SCCs in situ, voriconazole for 3 yrs
HIV, SCC, on voriconazole for 15 months
![Page 57: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/57.jpg)
Epaulard, Clin Microbiol Infect 2010;16:1362
Prior methotrexate, multiple SCCs on scalp, voriconazole for 2 yrs
CF & Lung Tx, aggressive SCCs, on voriconazole for 3.5 yrs
![Page 58: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/58.jpg)
Morice, Case Rep Med 2010
Multifocal Aggressive Squamous Cell Carcinomas Induced by Prolonged Voriconazole
Therapy
Pulmonary aspergillosis, skin carcinogenesis showed two variants of the MICR gene.
![Page 59: Antifungal skin reactions David W. Denning University Hospital of South Manchester The University of Manchester](https://reader036.vdocuments.us/reader036/viewer/2022062417/5515c3b955034689058b4679/html5/thumbnails/59.jpg)
Summary and questions
• Cutaneous adverse effects uncommon with itraconazole and posaconazole
• Acneiform eruption a new adverse event with posaconazole
• Photosensitivity, cheilitis and conjunctivitis common with voriconazole
• Photosensitivity may develop into carcinoma in situ, Bowen’s dieases, squamous cell carcinoma or melanoma.
• Photoaging not properly described separately• Mechanism of photosensitivity could involve elevated
retinol levels locally, but not understood• Is there a limit to the duration of treatment of caucasians
with voriconazole? • How should these patients be best monitored?